Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'STREPTOCOCCUS-PNEUMONIAE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2997 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sarachaga, MJ
      Difficulties in the diagnosis and treatment of acute lower respiratory tract infections in Uruguay

      PEDIATRIC PULMONOLOGY
    2. Risoen, PA; Johnsborg, O; Diep, DB; Hamoen, L; Venema, G; Nes, IF
      Regulation of bacteriocin production in Lactobacillus plantarum depends ona conserved promoter arrangement with consensus binding sequence

      MOLECULAR GENETICS AND GENOMICS
    3. Redfield, RJ
      Do bacteria have sex?

      NATURE REVIEWS GENETICS
    4. Gurtler, V; Mayall, BC
      Genomic approaches to typing, taxonomy and evolution of bacterial isolates

      INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
    5. Kempf, VAJ; Volkmann, B; Schaller, M; Sander, CA; Alitalo, K; Riess, T; Autenrieth, IB
      Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations

      CELLULAR MICROBIOLOGY
    6. Huang, SH; Jang, AY
      Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier

      CELLULAR MICROBIOLOGY
    7. Mohan, PV; Heath, PT
      Pneumococcal disease in childhood

      HOSPITAL MEDICINE
    8. Kleineidam, RG; Kruse, S; Roggentin, P; Schauer, R
      Elucidation of the role of functional amino acid residues of the small sialidase from Clostridium perfringens by site-directed mutagenesis

      BIOLOGICAL CHEMISTRY
    9. Pierce, AB; Hoy, JF
      Is the recommendation for pneumococcal vaccination of HIV patients evidence based?

      JOURNAL OF CLINICAL VIROLOGY
    10. Anderson, VE; Osheroff, N
      Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde

      CURRENT PHARMACEUTICAL DESIGN
    11. Markham, PN; Neyfakh, AA
      Efflux-mediated drug resistance in Gram-positive bacteria

      CURRENT OPINION IN MICROBIOLOGY
    12. Spratt, BG; Hanage, WP; Feil, EJ
      The relative contributions of recombination and point mutation to the diversification of bacterial clones

      CURRENT OPINION IN MICROBIOLOGY
    13. Rakkar, S; Roberts, K; Towe, BF; Flores, SM; Heyd, A; Warner, J
      Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    14. French, G
      Linezolid

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    15. O'Brien, K
      Disease transmission: Routes, contributing factors and herd immunity

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    16. Clanton, M
      Pneumococcal disease in United States children: Prevalence and treatment

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    17. Dagan, R
      Conjugate vaccines: Potential impact on antibiotic use?

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    18. Chan, MS; Maiden, MCJ; Spratt, BG
      Database-driven multi locus sequence typing (MLST) of bacterial pathogens

      BIOINFORMATICS
    19. Moore, JE; Millar, BC; Yongmin, X; Woodford, N; Vincent, S; Goldsmith, CE; McClurg, RB; Crowe, M; Hone, R; Murphy, PG
      A rapid molecular assay for the detection of antibiotic resistance determinants in causal agents of infective endocarditis

      JOURNAL OF APPLIED MICROBIOLOGY
    20. Dougherty, TJ; Beaulieu, D; Barrett, JF
      New quinolones and the impact on resistance

      DRUG DISCOVERY TODAY
    21. Bonfiglio, G; Furneri, PM
      Novel streptogramin antibiotics

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    22. Blondeau, JM
      Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    23. Dougherty, TJ; Barrett, JF
      ABT-773: a new ketolide antibiotic

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    24. Yassin, HM; Dever, LL
      Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    25. Jakubovics, NS; Jenkinson, HF
      Out of the iron age: new insights into the critical role of manganese homeostasis in bacteria

      MICROBIOLOGY-SGM
    26. Lindsay, JA; Foster, SJ
      zur: a Zn2+-responsive regulatory element of Staphylococcus aureus

      MICROBIOLOGY-SGM
    27. Foussard, M; Cabantous, S; Pedelacq, JD; Guillet, V; Tranier, S; Mourey, L; Birck, C; Samama, JP
      The molecular puzzle of two-component signaling cascades

      MICROBES AND INFECTION
    28. Mouton, JW; Jansz, AR
      The DUEL study: a multi-center in vitro, evaluation of linezolid compared with other antibiotics in the Netherlands

      CLINICAL MICROBIOLOGY AND INFECTION
    29. Gonullu, N; Aktas, Z; Salcioglu, M; Bal, C; Ang, O
      Comparative in vitro activities of five quinolone antibiotics, including gemifloxacin, against clinical isolates

      CLINICAL MICROBIOLOGY AND INFECTION
    30. Pantosti, A; D'Ambrosio, F; Bordi, E; d'Abusco, AS; Del Grosso, M
      Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy

      CLINICAL MICROBIOLOGY AND INFECTION
    31. Campos, J
      Haemophilus influenzae: from the post-vaccination era to antibiotic resistance

      CLINICAL MICROBIOLOGY AND INFECTION
    32. Bax, R; Bywater, R; Cornaglia, G; Goossens, H; Hunter, P; Isham, V; Jarlier, V; Jones, R; Phillips, I; Sahm, D; Senn, S; Struelens, M; Taylor, D; White, A
      Surveillance of antimicrobial resistance - what, how and whither?

      CLINICAL MICROBIOLOGY AND INFECTION
    33. Kragsbjerg, P; Fredlund, H
      The effects of live Streptococcus pneumoniae and tumor necrosis factor-alpha on neutrophil oxidative burst and beta 2-integrin expression

      CLINICAL MICROBIOLOGY AND INFECTION
    34. Jacobs, MR
      Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters

      CLINICAL MICROBIOLOGY AND INFECTION
    35. Esel, D; Sumerkan, B; Kocagoz, S
      Epidemiology of penicillin resistance in Streptococcus pneumoniae isolatesin Kayseri, Turkey

      CLINICAL MICROBIOLOGY AND INFECTION
    36. Paradisi, F; Corti, G; Cinelli, R
      Streptococcus pneumoniae as an agent of nosocomial infection: treatment inthe era of penicillin-resistant strains

      CLINICAL MICROBIOLOGY AND INFECTION
    37. Carbon, C
      Ketolides: An innovative solution to an evolving world of respiratory pathogens - Proceedings of a Symposium held at the 10th European Congress of Clinical Microbiology and Infectious Diseases - Stockholm, Sweden, 30 May 2000 - Introduction

      CLINICAL MICROBIOLOGY AND INFECTION
    38. Felmingham, D
      Microbiological profile of telithromycin, thee first ketolide antimicrobial

      CLINICAL MICROBIOLOGY AND INFECTION
    39. Leclercq, R
      Safeguarding future antimicrobial options: strategies to minimize resistance

      CLINICAL MICROBIOLOGY AND INFECTION
    40. Drusano, G
      Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin

      CLINICAL MICROBIOLOGY AND INFECTION
    41. Finch, R
      Community-acquired pneumonia: the evolving challenge

      CLINICAL MICROBIOLOGY AND INFECTION
    42. Koornhof, HJ; Keddy, K; McGee, L
      Clonal expansion of bacterial pathogens across the world

      JOURNAL OF TRAVEL MEDICINE
    43. Perry, CM; Goa, KL
      Community-acquired pneumonia and its management - The role of levofloxacin

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    44. Rubins, JB; Janoff, EN
      Pneumococcal disease in the elderly - What is preventing vaccine efficacy?

      DRUGS & AGING
    45. Obaji, A; Sethi, S
      Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?

      DRUGS & AGING
    46. Arias, RB; Lopez, MG; Sanchez, AP
      Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae

      JOURNAL OF CHEMOTHERAPY
    47. Gur, D; Guciz, B; Hascelik, G; Esel, D; Sumerkan, B; Over, U; Soyletir, G; Ongen, B; Kaygusuz, A; Toreci, K
      Streptococcus pneumoniae penicillin resistance in Turkey

      JOURNAL OF CHEMOTHERAPY
    48. Bantar, C; Nicola, F; Canigia, LF; Arenoso, HJ; Soutric, J; Montoto, M; Blanco, M; Smayevsky, J; Jasovich, A
      Rationale for treating community-acquired lower respiratory tract infections with amoxicillin/sulbactam combination through pharmacodynamic analysis in the setting of aminopenicillin-resistant organisms

      JOURNAL OF CHEMOTHERAPY
    49. Ball, P; Wilson, R; Mandell, L; Brown, J; Henkel, T
      Efficacy of gemifloxacin in acute exacerbations of chromic bronchitis: a randomised, double-blind comparison with trovafloxacin

      JOURNAL OF CHEMOTHERAPY
    50. Perez-Trallero, E; Alkorta, M; Gimenez, MJ; Vicente, D; Aguilar, L
      Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin

      JOURNAL OF CHEMOTHERAPY
    51. Eltahawy, ATAE
      Antimicrobial resistance of Streptococcus pneumoniae at a university hospital in Saudi Arabia

      JOURNAL OF CHEMOTHERAPY
    52. Mokaddas, EM; Wilson, S; Sanyal, SC
      Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait

      JOURNAL OF CHEMOTHERAPY
    53. McCullers, JA; Tuomanen, EI
      Molecular pathogenesis of pneumococcal pneumonia

      FRONTIERS IN BIOSCIENCE
    54. Jedrzejas, MJ
      Pneumococcal virulence factors: Structure and function

      MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    55. Chopra, I; Roberts, M
      Tetracycline antibiotics: Mode of action, applications, molecular biology,and epidemiology of bacterial resistance

      MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    56. Gmuender, H; Kuratli, K; Di Padova, K; Gray, CP; Keck, W; Evers, S
      Gene expression changes triggered by exposure of Haemophilus influenzae tonovobiocin or ciprofloxacin: Combined transcription and translation analysis

      GENOME RESEARCH
    57. Palavecino, EL
      The crisis of resistant pathogens in respiratory tract infections - Use ofpharmacodynamic principles

      AMERICAN JOURNAL OF MANAGED CARE
    58. Poole, MD
      Appropriate antibiotic use in treating respiratory tract infections

      AMERICAN JOURNAL OF MANAGED CARE
    59. Avigan, D; Pirofski, L; Lazarus, HM
      Vaccination against infectious disease following hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    60. McCarty, JM; Pierce, PF
      Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    61. Hooper, DC
      Emerging mechanisms of fluoroquinolone resistance

      EMERGING INFECTIOUS DISEASES
    62. Culley, CM; Lacy, MK; Klutman, N; Edwards, B
      Moxifloxacin: Clinical efficacy and safety

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    63. de las Rivas, B; Garcia, JL; Lopez, R; Garcia, P
      Molecular characterization of the pneumococcal teichoic acid phosphorylcholine esterase

      MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    64. Gravesen, A; Sorensen, K; Aarestrup, FM; Knochel, S
      Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics

      MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    65. Baddour, VT; Hugenberg, ST; Brandt, KD; Yang, EL
      Pneumococcal pyomyositis: A patient with diagnostic problems and complications

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    66. Niederman, MS; Mandell, LA; Anzueto, A; Bass, JB; Broughton, WA; Campbell, GD; Dean, N; File, T; Fine, MJ; Gross, PA; Martinez, F; Marrie, TJ; Plouffe, JF; Ramirez, J; Sarosi, GA; Torres, A; Wilson, R; Yu, VL
      Guidelines for the management of adults with community-acquired pneumonia - Diagnosis, assessment of severity, antimicrobial therapy, and prevention

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    67. Sullivan, JH; Mitchell, TJ; Steinhoff, MC
      Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    68. Bilwes, AM; Quezada, CM; Croal, LR; Crane, BR; Simon, MI
      Nucleotide binding by the histidine kinase CheA

      NATURE STRUCTURAL BIOLOGY
    69. Fernandez-Tornero, C; Lopez, R; Garcia, E; Gimenez-Gallego, G; Romero, A
      A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA

      NATURE STRUCTURAL BIOLOGY
    70. Mangione-Smith, R; McGlynn, EA; Elliott, MN; McDonald, L; Franz, CE; Kravitz, RL
      Parent expectations for antibiotics, physician-parent communication, and satisfaction

      ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    71. Freedman, SB; Marrocco, A; Pirie, J; Dick, PT
      Predictors of bacterial meningitis in the era after Haemophilus influenzae

      ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    72. Romero-Steiner, S; Fernandez, J; Biltoft, C; Wohl, ME; Sanchez, J; Feris, J; Balter, S; Levine, OS; Carlone, GM
      Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate)

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    73. Leiva, LE; Butler, B; Hempe, J; Ortigas, AP; Sorensen, RU
      Up-regulation of CD40 ligand and induction of a TH2 response in children immunized with pneumococcal polysaccharide vaccines

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    74. Jansen, WTM; Vakevainen-Anttila, M; Kayhty, H; Nahm, M; Bakker, N; Verhoef, J; Snippe, H; Verheul, AFM
      Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated witha pneumococcal conjugate vaccine

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    75. Concepcion, NF; Frasch, CE
      Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    76. Vakevainen, M; Jansen, W; Saeland, E; Jonsdottir, I; Snippe, H; Verheul, A; Kayhty, H
      Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    77. Lawrence, JG
      Catalyzing bacterial speciation: Correlating lateral transfer with geneticheadroom

      SYSTEMATIC BIOLOGY
    78. Empey, PE; Jennings, HR; Thornton, AC; Rapp, RP; Evans, ME
      Levofloxacin failure in a patient with pneumococcal pneumonia

      ANNALS OF PHARMACOTHERAPY
    79. Bain, KT; Wittbrodt, ET
      Linezolid for the treatment of resistant gram-positive cocci

      ANNALS OF PHARMACOTHERAPY
    80. Amsden, GW; Amankwa, K
      Pneumococcal resistance: The treatment challenge

      ANNALS OF PHARMACOTHERAPY
    81. Gonzales, R; Malone, DC; Maselli, JH; Sande, MA
      Excessive antibiotic use for acute respiratory infections in the United States

      CLINICAL INFECTIOUS DISEASES
    82. Moroney, JF; Fiore, AE; Harrison, LH; Patterson, JE; Farley, MM; Jorgensen, JH; Phelan, M; Facklam, RR; Cetron, MS; Breiman, RF; Kolczak, M; Schuchat, A
      Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance

      CLINICAL INFECTIOUS DISEASES
    83. Karstaedt, AS; Khoosal, M; Crewe-Brown, HH
      Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade

      CLINICAL INFECTIOUS DISEASES
    84. Le, TP; Miller, LG
      Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: A decision and cost analysis

      CLINICAL INFECTIOUS DISEASES
    85. Whitney, CG; Schaffner, W; Butler, JC
      Rethinking recommendations for use of pneumococcal vaccines in adults

      CLINICAL INFECTIOUS DISEASES
    86. Fraser, D; Givon-Lavi, N; Bilenko, N; Dagan, R
      A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: Implications for vaccine choice

      CLINICAL INFECTIOUS DISEASES
    87. Borer, A; Meirson, H; Peled, N; Porat, N; Dagan, R; Fraser, D; Gilad, J; Zehavi, N; Yagupsky, P
      Antibiotic-resistant pneumococci carried by young children do not appear to disseminate to adult members of a closed community

      CLINICAL INFECTIOUS DISEASES
    88. Klugman, KP
      Antibiotic selection of multiply resistant pneumococci

      CLINICAL INFECTIOUS DISEASES
    89. Okeke, IN; Edelman, R
      Dissemination of antibiotic-resistant bacteria across geographic borders

      CLINICAL INFECTIOUS DISEASES
    90. Drusano, GL; Preston, SL; Owens, RC; Ambrose, PG
      Fluoroquinolone pharmacodynamics

      CLINICAL INFECTIOUS DISEASES
    91. Schentag, JJ; Gilliland, KK; Paladino, JA
      Fluoroquinolone pharmacodynamics - Reply

      CLINICAL INFECTIOUS DISEASES
    92. Schutze, GE; Mason, EO; Wald, ER; Barson, WJ; Bradley, JS; Tan, TQ; Kim, KS; Givner, LB; Yogev, R; Kaplan, SL
      Pneumococcal infections in children after transplantation

      CLINICAL INFECTIOUS DISEASES
    93. Contopoulos-Ioannidis, DG; Koliofoti, ID; Koutroumpa, IC; Giannakakis, IA; Ioannidis, JPA
      Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: Arandomized trial

      CLINICAL INFECTIOUS DISEASES
    94. Kayhty, H; Ahman, H
      Bridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines

      CLINICAL INFECTIOUS DISEASES
    95. Tenover, FC
      Development and spread of bacterial resistance to antimicrobial agents: Anoverview

      CLINICAL INFECTIOUS DISEASES
    96. Courvalin, P; Trieu-Cuot, P
      Minimizing potential resistance: The molecular view

      CLINICAL INFECTIOUS DISEASES
    97. Zhao, XL; Drlica, K
      Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies

      CLINICAL INFECTIOUS DISEASES
    98. Hooper, DC
      Minimizing potential resistance: The molecular view - A comment on Courvalin and Trieu-Cuot

      CLINICAL INFECTIOUS DISEASES
    99. Levin, BR
      Minimizing potential resistance: A population dynamics view

      CLINICAL INFECTIOUS DISEASES
    100. Kristinsson, KG
      Mathematical models as tools for evaluating the effectiveness of interventions: A comment on Levin

      CLINICAL INFECTIOUS DISEASES


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 00:23:56